Overview

Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy

Status:
Withdrawn
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
This study is dedicated to determination of the long term effectiveness of coronary heart disease (CHD) treatments - cardiac shock wave therapy (CSWT) in comparison with other kinds of medical and surgical treatment. For that purpose the investigators will observe the patients with CHD who enrolled in this study in their routine course of treatment. But the investigators will not interfere with the patient treatment. Each participant will be followed-up for five years. The collected data will allow to determine if the particular method, CSWT, could really make any additional contribution to the more traditional methods of CHD treatment and if the CSWT is only temporarily effective or could exert the long term effect as well.
Details
Lead Sponsor:
City Hospital No 40, Saint Petersburg, Russia
Treatments:
Amlodipine
Aspirin
Atenolol
Enalapril
Enalaprilat
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Isosorbide
Isosorbide Dinitrate
Isosorbide-5-mononitrate
Nitroglycerin